Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the can rapid risk stratification of Unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) initiative

Daniel W. Mudrick, Anita Y. Chen, Matthew T. Roe, L. Kristin Newby, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson, Karen P. Alexander

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the can rapid risk stratification of Unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) initiative'. Together they form a unique fingerprint.

Medicine & Life Sciences